Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis
Shynar M. Maretbayeva, A Issayeva(Kazakh National Medical University), Askar Yedilbayev(World Health Organization Regional Office for Europe), Elmira Berikova, Michael Rich, Malik Adenov(Kazakh Institute of Oncology and Radiology), Yerkebulan Algozhin, Аnar Rakisheva(Kazakh National Medical University), Lyazzat Yeraliyeva, Kwonjune J. Seung(Partners In Health), Assel Stambekova
Cited by 14
Related Papers
Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe
|European Respiratory Journal|2019|130
Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
|PubMed|2006|94
<i>Treating Multidrug‐Resistant Tuberculosis in Tomsk, Russia</i>
|Annals of the New York Academy of Sciences|2008|59
Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death
|Clinical Infectious Diseases|2014|51